Cargando…
Chemical Modulation of the 1-(Piperidin-4-yl)-1,3-dihydro-2H-benzo[d]imidazole-2-one Scaffold as a Novel NLRP3 Inhibitor
In the search for new chemical scaffolds able to afford NLRP3 inflammasome inhibitors, we used a pharmacophore-hybridization strategy by combining the structure of the acrylic acid derivative INF39 with the 1-(piperidin-4-yl)1,3-dihydro-2H-benzo[d]imidazole-2-one substructure present in HS203873, a...
Autores principales: | Gastaldi, Simone, Boscaro, Valentina, Gianquinto, Eleonora, Sandall, Christina F., Giorgis, Marta, Marini, Elisabetta, Blua, Federica, Gallicchio, Margherita, Spyrakis, Francesca, MacDonald, Justin A., Bertinaria, Massimo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8271538/ https://www.ncbi.nlm.nih.gov/pubmed/34209843 http://dx.doi.org/10.3390/molecules26133975 |
Ejemplares similares
-
Investigation into the Use of Encorafenib to Develop Potential PROTACs Directed against BRAF(V600E) Protein
por: Marini, Elisabetta, et al.
Publicado: (2022) -
A Comparative Study on the Efficacy of NLRP3 Inflammasome Signaling Inhibitors in a Pre-clinical Model of Bowel Inflammation
por: Pellegrini, Carolina, et al.
Publicado: (2018) -
3-Oxo-5-(piperidin-1-yl)-2,3-dihydro-1H-pyrazole-4-carbonitrile
por: Al-Adiwish, Wedad M., et al.
Publicado: (2011) -
1,3-Diphenyl-3,4-dihydrobenzo[b][1,6]naphthyridine
por: Seebacher, Werner, et al.
Publicado: (2010) -
(3-Oxo-3H-benzo[f]chromen-1-yl)methyl piperidine-1-carbodithioate
por: Kotresh, O., et al.
Publicado: (2012)